Metformin can be safely used in patients exposed to contrast media: a systematic review and meta-analysis
Conclusion: Metformin can be safely applied in patients with moderate renal impairment as low as eGFR ≥30 ml/min/1.73 m2 during the exposure of the CM.
Source: Cardiology - Category: Cardiology Source Type: research
More News: Cardiology | Databases & Libraries | Fortamet | Heart | Metformin | Science | Statistics | Study | Urology & Nephrology